Private Shareholders

Being a Shareholder

As a Sanofi shareholder, you own a share in our capital, providing us with the resources we need to grow. By investing in our future, you are giving us a vote of confidence. Confidence is the cornerstone of the special relationship between us and our shareholders. We are committed to retaining and building your confidence by involving you in our development and giving you a share of our profits.

Stephane Poirier, Principal Scientist, Cambridge, USA

Fourth Quarter & Full Year 2024 Results

We exceeded expectations in 2024, achieving strong sales growth and significantly progressing our pipeline. Going forward, innovation will remain our key driver for launch excellence, as we become a fully focused, science-driven biopharma company.

Paul Hudson, Chief Executive Officer

Our Pipeline

5

Therapeutic areas

83

Compounds in clinical development

26

Clinical trials in phase 3

Sanofi France – Key figures

How to Hold Sanofi Shares

Sanofi ordinary shares can be held as:

  • Bearer shares: deposited with your financial intermediary,
  • Administered registered shares: deposited with your financial intermediary and recorded in the books of Sanofi,
  • Fully registered shares: deposited with and administered by Uptevia, transfer agent appointed by Sanofi. You benefit in this case from preferential rates for brokerage fees & bank commission and double voting rights when you have held your shares for at least two years

Uptevia fees for holding pure registered securities:

  • Free custody and administration fees
  • Bank commission of 7.62 euros per order
  • Brokerage fee: 0.45% with a minimum of 6.10 euros per order
Paul Hudson speaking at the Annual General Meeting 2024

Annual General Meeting 2024

The Sanofi General Meeting was held on April 30, 2024. 

Sanofi attended the Investir Day on November 26, 2024

Frequently Asked Questions From Individual Shareholders

In-Depth Reading

Shares